NADIASLY SANTILLANO CUESTA: Open Payments
NPI 1134595259 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 14 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $697 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| ABBVIE INC. | 2 | $57 |
| Exact Sciences Corporation | 2 | $46 |
| Amgen Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Dexcom, Inc. | 1 | $14 |
Products named: FARXIGA, Cologuard Collection Kit, CREON, FASENRA, QULIPTA, Repatha, Veozah, Dexcom G6 Transmitter.
Industry payments across NV — which companies pay providers there.
